Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

MRI technique may provide earlier cervical cancer diagnosis

Scientists funded by Cancer Research UK have revealed that it may be possible to identify cervical cancer in its early stages using a new magnetic resonance imaging (MRI)...

Radiotherapy before surgery slashes bowel cancer recurrence says trial

An international clinical trial has found a way to minimise the risk of tumour recurrence in bowel cancer patients to as little as one per cent.

Trial confirms benefit of 'exciting' new drug for advanced prostate cancer

Results of an international clinical trial have confirmed the benefits of enzalutamide, a new treatment for advanced prostate cancer.

Robert Plant confirmed for unique charity gig at Abbey Road

Rock fans have today been given the opportunity of a lifetime to see the legendary star Robert Plant play a unique and intimate gig in aid of Cancer Research UK.

Scientists use ‘virtual experiments’ to uncover missing cancer targets

Cancer Research UK-funded scientists have identified 46 previously overlooked but potentially 'druggable' cancer targets, using a powerful new online approach that allows...

Study links frequent multivitamin use and advanced prostate cancer

Men who take too many multivitamins could be increasing their risk of advanced prostate cancer, research has shown.

Tests of satraplatin for prostate cancer show encouraging results

The results of a phase III clinical trial of a new prostate cancer drug - satraplatin - have been encouraging, according to the drug companies involved.

Cancer patients urged to get financial advice on their retirement

Cancer Research UK has announced a new service to help people whose lives have been affected by cancer to get the most out of their hard-earned pension funds on retirement...

Scientists unravel breast cancer risk gene mystery

Scientists unravel breast cancer risk gene mystery

Prostate cancer drug abiraterone launched in UK

A new prostate cancer drug, developed with support from Cancer Research UK, has been launched in the UK following its licensing by the European Medicines Authority.